VOGELBAUM MARTIN

CIK 00012376245 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001237624

Recent Transactions

41 trades

Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2024-06-04+301,295→ 411,007 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2024-06-04+390,000→ 390,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2023-06-01+64,724→ 109,712 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2023-06-01+89,923→ 89,923 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2022-09-14$10.28/sh−10,800→ 44,988 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2022-06-02+23,752→ 43,912 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2022-06-02+33,993→ 33,993 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2022-06-02+11,876→ 55,788 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2021-06-07$13.05/sh−8,640→ 20,160 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2021-06-03+14,400→ 28,800 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2021-06-03+21,600→ 21,600 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-11-17$16.09/sh−6,000→ 14,400 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-06-04+21,600→ 21,600 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-06-04+14,400→ 20,400 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-06-04+6,000→ 6,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-06-04+6,000→ 6,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2019-06-04+9,000→ 9,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2018-06-06+18,000→ 18,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2017-06-21+15,000→ 15,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2016-06-15+15,000→ 15,000 total
Purchase
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2016-03-17$4.93/sh+247,727→ 3,068,057 total
Purchase
Tvardi Therapeutics, Inc.$TVRD
Common stock
2016-03-16$4.78/sh+152,273→ 2,820,330 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Options (Right to Buy)
2015-06-24$5.03/sh+12,000→ 21,857 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2015-06-08+13,500→ 13,500 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−494,447→ 0 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−5,631,531→ 0 total
Conversion
NephroGenex, Inc.
Convertible Promissory Note
2014-02-14−1,215,268→ 0 total
Conversion
NephroGenex, Inc.
Convertible Promissory Note
2014-02-14−106,697→ 0 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14+1,215,268→ 1,215,268 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−1,215,268→ 0 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14+106,697→ 106,697 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−106,697→ 0 total
Conversion
NephroGenex, Inc.
Common Stock
2014-02-14+942,455→ 942,455 total
Conversion
NephroGenex, Inc.
Common Stock
2014-02-14+203,374→ 1,145,829 total
Award
NephroGenex, Inc.
Common Stock
2014-02-14+180,997→ 1,326,826 total
Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2014-02-05+2,442,239→ 2,442,239 total
Purchase
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2014-02-05$11.00/sh+225,818→ 2,668,057 total
Conversion
Tvardi Therapeutics, Inc.$TVRD
Series D Preferred Stock
2014-02-05−6,105,598→ 0 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2014-01-30+20,000→ 20,000 total
Award
MiddleBrook Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2009-06-23+20,000→ 20,000 total
Award
MiddleBrook Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2007-04-20+30,000→ 30,000 total

Companies

Recent Filings

Address

RHO CAPITAL PARTNERS 152 WEST 57TH STREET, 23RD FLOOR

NEW YORK, NY, 10019

View on SEC.gov